MGNX
Price
$1.65
Change
-$0.04 (-2.37%)
Updated
Oct 17 closing price
Capitalization
104.29M
24 days until earnings call
Intraday Buy/Sell Signals
TCRX
Price
$2.48
Change
-$0.00 (-0.00%)
Updated
Oct 17 closing price
Capitalization
140.74M
18 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

MGNX vs TCRX

Header iconMGNX vs TCRX Comparison
Open Charts MGNX vs TCRXBanner chart's image
MacroGenics
Price$1.65
Change-$0.04 (-2.37%)
Volume$464.53K
Capitalization104.29M
TScan Therapeutics
Price$2.48
Change-$0.00 (-0.00%)
Volume$711.92K
Capitalization140.74M
MGNX vs TCRX Comparison Chart in %
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MGNX vs. TCRX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGNX is a Hold and TCRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (MGNX: $1.65 vs. TCRX: $2.48)
Brand notoriety: MGNX and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGNX: 62% vs. TCRX: 161%
Market capitalization -- MGNX: $104.29M vs. TCRX: $140.74M
MGNX [@Biotechnology] is valued at $104.29M. TCRX’s [@Biotechnology] market capitalization is $140.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGNX’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • MGNX’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, TCRX is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGNX’s TA Score shows that 4 TA indicator(s) are bullish while TCRX’s TA Score has 7 bullish TA indicator(s).

  • MGNX’s TA Score: 4 bullish, 4 bearish.
  • TCRX’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, TCRX is a better buy in the short-term than MGNX.

Price Growth

MGNX (@Biotechnology) experienced а -2.37% price change this week, while TCRX (@Biotechnology) price change was +12.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

MGNX is expected to report earnings on Nov 11, 2025.

TCRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TCRX($141M) has a higher market cap than MGNX($104M). TCRX YTD gains are higher at: -18.421 vs. MGNX (-49.231). MGNX has higher annual earnings (EBITDA): -26.91M vs. TCRX (-130.55M). TCRX has more cash in the bank: 218M vs. MGNX (176M). MGNX has less debt than TCRX: MGNX (37.2M) vs TCRX (96.7M). MGNX has higher revenues than TCRX: MGNX (164M) vs TCRX (6.96M).
MGNXTCRXMGNX / TCRX
Capitalization104M141M74%
EBITDA-26.91M-130.55M21%
Gain YTD-49.231-18.421267%
P/E RatioN/AN/A-
Revenue164M6.96M2,356%
Total Cash176M218M81%
Total Debt37.2M96.7M38%
FUNDAMENTALS RATINGS
MGNX: Fundamental Ratings
MGNX
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MGNXTCRX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HKHHY35.730.40
+1.13%
Heineken Holding N.V.
FGPHF0.09N/A
N/A
First Graphene Limited
ICHBF9.92N/A
N/A
Industrias CH
NSVGF0.01N/A
N/A
Nass Vy Gateway Ltd.
SCZMF1.58-0.27
-14.59%
Santacruz Silver Mining Ltd.

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with MGNX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then MGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
N/A
MGNX - TCRX
44%
Loosely correlated
-2.37%
FATE - TCRX
41%
Loosely correlated
-4.55%
ZNTL - TCRX
39%
Loosely correlated
-4.49%
XNCR - TCRX
39%
Loosely correlated
-1.20%
STRO - TCRX
39%
Loosely correlated
+14.68%
More